​
Login / Signup
Akram Shalaby
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 2
Top Topics
Reactive Oxygen Species
Open Label
Chemotherapy Induced
Pi K Akt
Top Venues
Cancer research
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Mehrdad Zarei
,
Omid Hajihassani
,
Jonathan J Hue
,
Alexander W Loftus
,
Hallie J Graor
,
Faith Nakazzi
,
Parnian Naji
,
Christina S Boutros
,
Vinayak Uppin
,
Ali Vaziri-Gohar
,
Akram Shalaby
,
John M Asara
,
Luke D Rothermel
,
Jonathan R Brody
,
Jordan M Winter
IDH1 inhibition potentiates chemotherapy efficacy in pancreatic cancer.
Cancer research
(2024)
Rikita I Hatia
,
Madhulika Eluri
,
Ernest T Hawk
,
Akram Shalaby
,
Elif Karatas
,
Ahmed Shalaby
,
Ahmed A Abdelhakeem
,
Reham Abdel-Wahab
,
Ping Chang
,
Asif Rashid
,
Prasun Kumar Jalal
,
Christopher Ian Amos
,
Younghun Han
,
Tannaz Armaghany
,
Rachna T Shroff
,
Dounghui Li
,
Milind M Javle
,
Manal M Hassan
Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity is Associated with Cholangiocarcinoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
(2023)